BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24980445)

  • 1. Analysis of incidence and prognosis from 'extreme' case-control designs.
    Salim A; Ma X; Fall K; Andrén O; Reilly M
    Stat Med; 2014 Dec; 33(30):5388-98. PubMed ID: 24980445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A maximum likelihood method for secondary analysis of nested case-control data.
    Salim A; Xiangmei M; Jialiang L; Reilly M
    Stat Med; 2014 May; 33(11):1842-52. PubMed ID: 24753004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the matched extreme case-control design more powerful than the nested case-control design?
    Støer NC; Salim A; Bokenberger K; Karlsson I; Reilly M
    Stat Methods Med Res; 2019 Jun; 28(6):1911-1923. PubMed ID: 29927359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies.
    van der Net JB; Janssens AC; Eijkemans MJ; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Eur J Hum Genet; 2008 Sep; 16(9):1111-6. PubMed ID: 18382476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse probability weighting in nested case-control studies with additional matching--a simulation study.
    Støer NC; Samuelsen SO
    Stat Med; 2013 Dec; 32(30):5328-39. PubMed ID: 24132909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A weighted Cox model for modelling time-dependent exposures in the analysis of case-control studies.
    Leffondre K; Wynant W; Cao Z; Abrahamowicz M; Heinze G; Siemiatycki J
    Stat Med; 2010 Mar; 29(7-8):839-50. PubMed ID: 20213717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Clinical Cohort Data Using Nested Case-control and Case-cohort Sampling Designs. A Powerful and Economical Tool.
    Ohneberg K; Wolkewitz M; Beyersmann J; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Schumacher M
    Methods Inf Med; 2015; 54(6):505-14. PubMed ID: 26108707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer.
    Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M
    BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum likelihood estimation for Cox's regression model under nested case-control sampling.
    Scheike TH; Juul A
    Biostatistics; 2004 Apr; 5(2):193-206. PubMed ID: 15054025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which patients to sample in clinical cohort studies when the number of events is high and measurement of additional markers is constrained by limited resources.
    Edelmann D; Ohneberg K; Becker N; Benner A; Schumacher M
    Cancer Med; 2020 Oct; 9(20):7398-7406. PubMed ID: 32813923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of case-control age-at-onset data using a modified case-cohort method.
    Nan B; Lin X
    Biom J; 2008 Apr; 50(2):311-20. PubMed ID: 18318038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crude incidence in two-phase designs in the presence of competing risks.
    Rebora P; Antolini L; Glidden DV; Valsecchi MG
    BMC Med Res Methodol; 2016 Jan; 16():5. PubMed ID: 26754746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estimation of average hazard ratios by weighted Cox regression.
    Schemper M; Wakounig S; Heinze G
    Stat Med; 2009 Aug; 28(19):2473-89. PubMed ID: 19472308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort case-control design and analysis for clustered failure-time data.
    Lu SE; Wang MC
    Biometrics; 2002 Dec; 58(4):764-72. PubMed ID: 12495130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
    Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
    BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point.
    Graziano F; Valsecchi MG; Rebora P
    BMC Med Res Methodol; 2021 Apr; 21(1):93. PubMed ID: 33941092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.